 "Weekly stock picks by Religare Broking: Buy Aurobindo Pharma, Marico")
Buy Aurobindo Pharma Limited
Last Close: Rs 879.25
Initiation range: Rs 875-880
Target: Rs 930
Stop loss: Rs 845
Aurobindo Pharma has witnessed a fresh breakout from a consolidation range on November 24, with a noticeable rise in the volume. The chart pattern and positioning of oscillators are pointing towards a sharp up move in the near future. We advise creating fresh longs in the given range.
Also Read
Buy Dr. Reddy's Laboratories Limited
Last Close: Rs 4,915.50
Initiation range: Rs 4,910-4,920
Target: Rs 5,200
Stop loss: Rs 4,770
The pharma pack looks set for a rebound after three months of consolidation. Among the stocks, Dr. Reddy’s has also witnessed decent retracement from its record high and formed a base above the support zone of the medium-term moving average (100 EMA) on the daily chart. Indications are in the favor of a swift rebound soon. We thus advise creating fresh longs within the mentioned zone.
Buy Marico Limited
Last Close: Rs 378.05
Initiation range: Rs 376-379
Target:Rs 405
Stop loss: Rs 365
We’re seeing fresh traction in the defensive pack but participation is restricted to a select few so far. Marico has been consolidating in a range of 340-380 zone for the last two months and trading on the verge of a breakout now. Traders shouldn’t miss this opportunity and create fresh longs in the given range.
Disclaimer: Ajit Mishra is VP - Research at Religare Broking
http://www.religareonline.com/disclaimer
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%